The following is a summary of “Visual Outcomes and Patient Satisfaction of Two Continuous Range of Vision Intraocular Lenses, ...

Long-term stabilizing of retinal exudation and fluid accumulation contributes to brolucizumab’s efficacy in managing wet age-related macular degeneration (AMD). Visual prognosis could be improved when ...

MS can cause a wide variety of neuro-ophthalmic manifestations and is also associated in some cases with uveitis. Intermediate uveitis, characterized by vitreous inflammation and peripheral ...

Intermediate and posterior uveitis account for much of the visual loss associated with uveitis. Systemic corticosteroids are used initially as they are fast acting, potent and inexpensive ...

Goldberg said anterior uveitis comes with pain, light sensitivity and redness; intermediate uveitis comes with floaters and blurred vision; posterior uveitis comes with blurred vision, blind spot ...

InflammX’s pipeline includes an orally dosed therapeutic candidate targeting intermediate age-related macular degeneration. InflammX Therapeutics, Inc. has entered into an option agreement granting ...

enVista Aspire combines novel Intermediate Optimized optics, which are designed for a broader depth of focus*, with the proven benefits of the enVista ® platform to address vision needs in today ...

enVista Aspire combines novel Intermediate Optimized optics ... Recurrent severe anterior or posterior segment inflammation or uveitis; (2) Patients in whom the IOL may affect the ability to observe, ...